tiprankstipranks
Cytek Biosciences (CTKB)
NASDAQ:CTKB
US Market
CTKB
Cytek Biosciences
RESEARCH TOOLSreports
Want to see CTKB full AI Analyst Report?

Cytek Biosciences (CTKB) Income Statement

105 Followers

Cytek Biosciences Income Statement

Last quarter (Q4 2025), Cytek Biosciences's total revenue was $62.14M, an increase of 8.12% from the same quarter last year. In Q4, Cytek Biosciences's net income was $-44.08M. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 201.49M$ 200.45M$ 193.01M$ 164.04M$ 127.95M
Gross Profit
$ 104.46M$ 111.11M$ 109.43M$ 100.97M$ 79.14M
Operating Expenses
$ 144.84M$ 131.63M$ 137.27M$ 102.78M$ 69.99M
Depreciation and Amortization
$ 11.97M$ 10.49M$ 9.23M$ 5.66M$ 1.24M
EBITDA
$ -17.39M$ -10.03M$ -4.41M$ 9.49M$ 8.92M
Operating Income
$ -40.38M$ -20.52M$ -27.84M$ -1.80M$ 9.16M
Other Income/Expenses
$ 10.54M$ 14.82M$ 12.14M$ 3.06M$ -3.22M
Pretax Income
$ -29.84M$ -5.70M$ -15.71M$ 1.26M$ 5.94M
Net Income
$ -66.54M$ -6.02M$ -12.15M$ 2.58M$ 3.00M
Per Share Metrics
Basic EPS
$ -0.52$ -0.05$ -0.09$ 0.02$ 0.03
Diluted EPS
$ -0.52$ -0.05$ -0.09$ 0.02$ 0.03
Weighted Average Shares Outstanding
 127.75M 130.61M 135.28M 134.51M 133.75M
Weighted Average Shares Outstanding (Diluted)
 127.75M 130.61M 135.28M 138.56M 133.75M
Currency in USD

Cytek Biosciences Earnings and Revenue History